RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Oric Pharmaceuticals Stock

Oric Pharmaceuticals Revenue 2024

Oric Pharmaceuticals Revenue

0 USD

Ticker

ORIC

ISIN

US68622P1093

WKN

A2P208

In 2024, Oric Pharmaceuticals's sales reached 0 USD, a 0% difference from the 0 USD sales recorded in the previous year.

The Oric Pharmaceuticals Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e428.5-
2028e230.87-
2027e48.35-
2026e19.79-
2025e--
2024e--
2023--
2022--
2021--
2020--
2019--
2018--

Oric Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Oric Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Oric Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Oric Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Oric Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Oric Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Oric Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Oric Pharmaceuticals’s growth potential.

Oric Pharmaceuticals Revenue, EBIT and net profit per share

DateOric Pharmaceuticals RevenueOric Pharmaceuticals EBITOric Pharmaceuticals Net Income
2029e428.5 M undefined0 undefined300.03 M undefined
2028e230.87 M undefined72.51 M undefined62.6 M undefined
2027e48.35 M undefined-174.74 M undefined-152.3 M undefined
2026e19.79 M undefined-167.2 M undefined-155.69 M undefined
2025e0 undefined-149.92 M undefined-150.15 M undefined
2024e0 undefined-126.92 M undefined-130.03 M undefined
20230 undefined-110.78 M undefined-100.7 M undefined
20220 undefined-91.77 M undefined-89.12 M undefined
20210 undefined-78.87 M undefined-78.72 M undefined
20200 undefined-49.35 M undefined-73.7 M undefined
20190 undefined-28.57 M undefined-26.88 M undefined
20180 undefined-22.37 M undefined-21.36 M undefined

Oric Pharmaceuticals stock margins

The Oric Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Oric Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Oric Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Oric Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Oric Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Oric Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Oric Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Oric Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Oric Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Oric Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Oric Pharmaceuticals Margin History

Oric Pharmaceuticals Gross marginOric Pharmaceuticals Profit marginOric Pharmaceuticals EBIT marginOric Pharmaceuticals Profit margin
2029e0 %0 %70.02 %
2028e0 %31.41 %27.11 %
2027e0 %-361.44 %-315.02 %
2026e0 %-844.75 %-786.59 %
2025e0 %0 %0 %
2024e0 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %

Oric Pharmaceuticals Aktienanalyse

What does Oric Pharmaceuticals do?

Oric Pharmaceuticals Inc. is a biotechnology company focused on the discovery and development of novel therapeutic approaches for cancer. The company was founded in 2014 by an experienced management team and reputable investors with extensive knowledge in the development and commercialization of cancer drugs. The company is headquartered in Durham, North Carolina, USA. Oric Pharmaceuticals operates a unique business model that focuses on the development of drugs that specifically target cancer cells, thereby increasing therapeutic effectiveness and reducing side effects. The company utilizes a combination of advanced technologies such as genomics, proteomics, and artificial intelligence to develop novel compounds and treatment approaches. The company conducts its research in two business areas: 1) Refinement of the Oric-006 program: The Oric-006 program is a focus of Oric Pharmaceuticals, involving a novel approach to combating cancer. The company has discovered that the protein kinase inhibitor, or Oric-006, is capable of killing tumor cells in patients with advanced tumors. Additionally, the medication is able to slow the spread and inhibit the growth of cancer cells. The company is researching the refinement of Oric-006 and is currently in phase 1b/2 clinical trials. 2) Development of additional compounds: Oric Pharmaceuticals focuses on the development of further therapeutic approaches that can be specifically utilized against specific types of cancer. The company is working on various technologies and platforms to develop new compounds and test their effects against cancer cells. Oric Pharmaceuticals' products have the potential to positively impact the lives of cancer patients and reduce the need for chemotherapy and radiation therapy. The company recognizes the necessity for personalized medicine and utilizes it in the identification of new therapeutic approaches. The company plans to bring its products to market through partnerships and targeted marketing. Oric Pharmaceuticals collaborates closely with experts and leading research institutions for the marketing of their products. Overall, Oric Pharmaceuticals is an innovative company that could play a leading role in the industry due to its focus on personalized cancer medicine and the utilization of cutting-edge technologies. With an experienced management team and reputable investors, the company is positioned for further growth in the future. Oric Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Oric Pharmaceuticals's Sales Figures

The sales figures of Oric Pharmaceuticals originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Oric Pharmaceuticals’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Oric Pharmaceuticals's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Oric Pharmaceuticals’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Oric Pharmaceuticals stock

How much revenue did Oric Pharmaceuticals generate this year?

Oric Pharmaceuticals has achieved a revenue of 0 USD this year.

How much was the turnover of the company Oric Pharmaceuticals compared to the previous year?

The revenue of Oric Pharmaceuticals has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Oric Pharmaceuticals?

The revenue of Oric Pharmaceuticals is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Oric Pharmaceuticals measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Oric Pharmaceuticals so important for investors?

The revenue of Oric Pharmaceuticals is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Oric Pharmaceuticals pay?

Over the past 12 months, Oric Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oric Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Oric Pharmaceuticals?

The current dividend yield of Oric Pharmaceuticals is .

When does Oric Pharmaceuticals pay dividends?

Oric Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oric Pharmaceuticals?

Oric Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Oric Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oric Pharmaceuticals located?

Oric Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oric Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oric Pharmaceuticals from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Oric Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Oric Pharmaceuticals in the year 2023?

In the year 2023, Oric Pharmaceuticals distributed 0 USD as dividends.

In which currency does Oric Pharmaceuticals pay out the dividend?

The dividends of Oric Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Oric Pharmaceuticals

Our stock analysis for Oric Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oric Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.